Prolongation of Murine Cardiac Allograft Survival with Vesnarinone

Author： Hirozane T.   Matsumori A.   Furukawa Y.   Matsui S.   Matoba Y.   Sasayama S.  

Publisher： Academic Press

ISSN： 0022-2828

Source： Journal of Molecular and Cellular Cardiology, Vol.29, Iss.1, 1997-01, pp. : 67-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of Cardiac Allograft Rejection by T Lymphocytes

By DeBruyne L.A.   Piccotti J.R.   Bishop D.K.  

Trends in Cardiovascular Medicine, Vol. 6, Iss. 5, 1996-07 ,pp. : 168-173

Elsevier

Access to resources Recommend Favorite

Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy

By Doshi A.A.   Rogers J.   Kern M.J.   Hauptman P.J.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 90-92

Elsevier

Access to resources Recommend Favorite

Impact of Immunosuppressive Drugs on the Development of Cardiac Allograft Vasculopathy

By  

Current Vascular Pharmacology, Vol. 8, Iss. 5, 2010-09 ,pp. : 706-719

Bentham Science Publishers

Access to resources Recommend Favorite

PR Prolongation and Cardiac 123I-MIBG Uptake Reduction in Parkinson's Disease

By  

European Neurology, Vol. 74, Iss. 1-2, 2015-08 ,pp. : 107-111

Karger

Access to resources Recommend Favorite

Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions

By  

Current Vascular Pharmacology, Vol. 8, Iss. 2, 2010-03 ,pp. : 169-188

Bentham Science Publishers

Access to resources Recommend Favorite